推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

BIOCHEMICAL PHARMACOLOGY

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 BIOCHEM PHARMAC最新评论:我半个月状态是“with editor”,然后直接“dip",准备换其他期刊了 (2024-03-24)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


BIOCHEMICAL PHARMACOLOGY期刊基本信息Hello,您是该期刊的第188485位访客

基本信息 登录收藏
期刊名字BIOCHEMICAL PHARMACOLOGYBIOCHEMICAL PHARMACOLOGY

BIOCHEM PHARMACOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.0
69人评分
我要评分

声誉
8.7

影响力
7.0

速度
9.3

期刊ISSN0006-2952
微信扫码收藏此期刊
E-ISSN1873-2968
2022-2023最新影响因子
(数据来源于搜索引擎)
5.8 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:4.573
2022-2023自引率1.70%点击查看自引率趋势图
五年影响因子5.8
h-index 181
CiteScore
CiteScoreSJRSNIPCiteScore排名
9.801.3291.155
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q139 / 301
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Biochemistry
Q161 / 428

期刊简介
Biochemical Pharmacology publishes original research findings, Commentaries and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics.
The journal's target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process.
All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complimentary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review.
While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.
期刊官方网站http://www.elsevier.com/wps/find/journaldescription.cws_home/525454/description#description
期刊投稿网址https://www.editorialmanager.com/BP
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足BIOCHEMICAL PHARMACOLOGY的语言要求,还能让BIOCHEMICAL PHARMACOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被BIOCHEMICAL PHARMACOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB
出版商Elsevier Inc.
涉及的研究方向医学-药学
出版国家或地区UNITED STATES
出版语言English
出版周期Semimonthly
出版年份1958
年文章数 405点击查看年文章数趋势图
Gold OA文章占比11.74%
研究类文章占比:
文章 ÷(文章 + 综述)
64.94%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:PHARMACOLOGY & PHARMACY
类别:SCIE
Q140/277
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区4区
PHARMACOLOGY & PHARMACY
药学
4区4区2区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区2区3区
PHARMACOLOGY & PHARMACY
药学
1区4区2区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区3区
PHARMACOLOGY & PHARMACY
药学
2区2区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0006-2952%5BISSN%5D
平均审稿速度网友分享经验:
平均1.0个月
来源Elsevier官网:
平均3.3周
平均录用比例网友分享经验:
约50%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在BIOCHEMICAL PHARMACOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
在线出版周期来源Elsevier官网:
平均9周
期刊常用信息链接
同领域相关期刊 BIOCHEMICAL PHARMACOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 BIOCHEMICAL PHARMACOLOGY中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
BIOCHEMICAL PHARMACOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    DRUG RESISTANCE UPDATES10034.80
    PHARMACOLOGICAL REVIEWS21030.70
    ADVANCED DRUG DELIVERY REVIEWS27823.30
    TRENDS IN PHARMACOLOGICAL SCIENCES20123.30
    PHARMACOLOGY & THERAPEUTICS18021.10
    MEDICINAL RESEARCH REVIEWS11926.60
    PHARMACOLOGICAL RESEARCH11815.80
    PHYTOMEDICINE10510.40
    BIOMEDICINE & PHARMACOTHERAPY7812.60
    DRUG DISCOVERY TODAY15714.70
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE599660
    BIOMATERIALS512540
    BIOMEDICINE & PHARMACOTHERAPY461618
    Journal of Materials Chemistry B458269
    Frontiers in Pharmacology448053
    Frontiers in Immunology418935
    JOURNAL OF ETHNOPHARMACOLOGY403391
    COLLOIDS AND SURFACES B-BIOINTERFACES402988
    Frontiers in Oncology382339
    Acta Biomaterialia374476
  •  

    BIOCHEMICAL PHARMACOLOGY BIOCHEMICAL PHARMACOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Sirtuin1-p53: A potential axis for cancer therapy

    Author: Yin, Jia-yi; Lu, Xin-tong; Hou, Meng-ling; Cao, Ting; Tian, Zhen
    Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 212, Issue , pp. -. DOI: 10.1016/j.bcp.2023.115543
        PubMed      DOI
    2.Inhibition of STX17-SNAP29-VAMP8 complex formation by costunolide sensitizes ovarian cancer cells to cisplatin via the AMPK/mTOR signaling pathway

    Author: Liang, Xiao; Yu, Chunlei; Tian, Yunhong; Xiang, Xiaocong; Luo, Yuexi
    Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 212, Issue , pp. -. DOI: 10.1016/j.bcp.2023.115549
        PubMed      DOI
    3.Activated AMPK mitigates diabetes-related cognitive dysfunction by inhibiting hippocampal ferroptosis

    Author: Xie, Zheng; Wang, Xuan; Luo, Xiaoxiao; Yan, Jing; Zhang, Jie; Sun, Rao; Luo, Ailin; Li, Shiyong
    Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115374
        PubMed      DOI
    4.The role of Notch signaling pathway in metabolic bone diseases

    Author: Gao, Yongguang; Fu, Zhanda; Guan, Junxia; Liu, Xinhua; Zhang, Qing
    Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115377
        PubMed      DOI
    5.Dipyridamole interacts with the N-terminal domain of HSP90 and antagonizes the function of the chaperone in multiple cancer cell lines

    Author: Gao, Jing; Zhou, Chen; Zhong, Yan; Shi, Li; Luo, Xuanyang; Su, Haixia; Li, Minjun; Xu, Yechun; Zhang, Naixia; Zhou, Hu
    Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115376
        PubMed      DOI
    6.Upregulation of PIK3IP1 monitors the anti-cancer activity of PI3K alpha inhibitors in gastric cancer cells

    Author: Ma, Xu-Bin; Wang, Yang; Jia, Ying-Jie; Liu, Ya-Jie; Tian, Ying-Qi; Liu, Ying; Hou, Gui-Qin; Xu, Yi-Chao; Liu, Hong-Min
    Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115380
        PubMed      DOI
    7.Exploring the potential molecular mechanism of trastuzumab-induced cardiotoxicity based on RNA sequencing and bioinformatics analysis

    Author: Hou, Huan; Xu, Ying; Xie, Meilin; Chen, Rong
    Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 208, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115388
        PubMed      DOI
    8.Role of prostaglandin E2 in macrophage polarization: Insights into atherosclerosis

    Author: Wang, Weixuan; Liang, Mingjie; Wang, Lexun; Bei, Weijian; Rong, Xianglu; Xu, Jianqin; Guo, Jiao
    Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115357
        PubMed      DOI
    9.SIRT3 attenuates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome via autophagy

    Author: Sun, Zhengzhu; Fang, Chongfeng; Xu, Shasha; Wang, Bin; Li, Danlei; Liu, Xiaoman; Mi, Yafei; Guo, Hangyuan; Jiang, Jianjun
    Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115354
        PubMed      DOI
    10.Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease

    Author: Ren, Ying; Zhu, Xiaodan; Fu, Kequan; Zhang, Haoran; Zhao, Wenchao; Lin, Yang; Fang, Qian; Wang, Junqi; Chen, Yupeng; Guo, Dong
    Journal: BIOCHEMICAL PHARMACOLOGY. 2023; Vol. 207, Issue , pp. -. DOI: 10.1016/j.bcp.2022.115355
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共365条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451